Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Kunal Ramesh Chandekar; Swayamjeet Satapathy; Sanjana Ballal; Madhav Prasad Yadav; Shubha Gadde Ravindra; Sameer Rastogi; Ranjit Kumar Sahoo; Chandrasekhar Bal

doi:10.2967/jnumed.125.269456

Research ArticleClinical Investigation

Clinical Outcomes of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo and Chandrasekhar Bal

Journal of Nuclear Medicine May 2025, jnumed.125.269456; DOI: https://doi.org/10.2967/jnumed.125.269456

Kunal Ramesh Chandekar

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Swayamjeet Satapathy

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sanjana Ballal

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Madhav Prasad Yadav

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shubha Gadde Ravindra

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sameer Rastogi

2Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ranjit Kumar Sahoo

2Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chandrasekhar Bal

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 6

June 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Clinical Outcomes of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo, Chandrasekhar Bal

Journal of Nuclear Medicine May 2025, jnumed.125.269456; DOI: 10.2967/jnumed.125.269456

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Clinical Outcomes of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo, Chandrasekhar Bal

Journal of Nuclear Medicine May 2025, jnumed.125.269456; DOI: 10.2967/jnumed.125.269456

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

neuroendocrine tumors
skeletal metastases
peptide receptor radionuclide therapy
177Lu-DOTATATE
skeletal-related events

Main menu

User menu

Search

Clinical Outcomes of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords